Two studies presented at ASCO's virtual annual meeting demonstrated the clinical utility of germline findings in guiding treatment decisions in cancer.
New data shows that the test could eventually be useful in helping younger women avoid chemotherapy in the neoadjuvant setting.
Polygenic Risk Score, Family History Refine Breast Cancer Risk Assessment in CHEK2 Mutation Carriers
Breast cancer risk in carriers of pathogenic CHEK2 variants may be classified as low, moderate, or high by adding in polygenic risk score and family history data.
The INFORM study echoed the 2019 interim results from the NCI Pediatric MATCH trial, which found that 24 percent of participants were eligible for targeted treatment.
The template describes the data and information that should be submitted for EUA of collection kits or tests with a home self-collection component.
Fresh off a new investment round, the British firm seeks to help research labs and biopharma companies manage population-level genomics research.
The DXRX marketplace, planned for launch in the fourth quarter of 2020, will provide a way for pharmaceutical companies, diagnostic firms, and laboratories to collaborate.
The infectious disease testing firm has developed a sequencing-based coronavirus assay, which it plans to commercialize through its sister firm BioID Genomics.
The researchers also found that COVID-19 patients had a special trigger host immune response in certain pathways, such as interferon gamma signaling.
In the near term, the firm will launch a laboratory-developed, late-stage lung cancer assay out of its lab in Palo Alto.
Investigators explored population dynamics during the shift to farming with new sequence data from more than 100 individuals from present-day France and Germany.
Rady's Children Hospital and San Diego County are teaming up to test pediatric patients and their families for COVID-19 to gauge the spread of the virus locally, according to the San Diego Union-Tribune.
Wildlife managers aim to boost the genetic diversity of Mexican gray wolves by placing captive-born foster pups into packs with similarly aged wild pups, the Mercury News reports.
In Science this week: Genetic Probability tool identifies likely diagnoses in 45 percent of inflammatory arthritis cases, and more.
A new microbiome analysis uncovered cancer type-specific bacterial community features, along with intracellular bacteria in tumor and associated immune cells.
The approach is essentially a simplified version of the technology in Fluidigm's CyTOF instruments, using metal-linked antibodies to measure proteins.
The deal will join Tangen's GeneSpark point-of-care instrument with LabWare's portable disease surveillance kit for SARS-CoV-2.
The company said that a large portion of the offering's proceeds would be used to end criminal and civil investigations over its past billing practices.
OraSure Technologies has appointed Lelio Marmora as a member of the company's board of directors, effective June 1. Marmora previously served as executive director of Unitaid and also held senior positions at the Global Fund to Fight AIDS, TB and, Malaria.
The test uses a proprietary at-home PCR nasal swab test with a turnaround time of 24 hours and is authorized for use by at-risk people.